Yemen, UNDP sign agreement to strengthen HIV/AIDS control efforts

NewsGuard 100/100 Score

Officials from Yemen and the United Nations Development Programme on Monday signed a $10.6 million, three-year agreement to strengthen efforts to fight HIV/AIDS in the country, SABA News reports.

The agreement was signed by Abdul-Karim al-Arhabi, Yemen's minister of Planning and International Cooperation, and UNDP Acting Resident Representative Selva Ramachandran.

The program -- which is supported by the Global Fund To Fight AIDS, Tuberculosis and Malaria -- aims to bolster the government's efforts to control the spread of HIV/AIDS within the general population and high-risk groups. It seeks to ensure that the rights of people living with HIV/AIDS, including the right to appropriate medical care, are guaranteed by 2010.

The program also aims to expand coverage of safe blood for transfusions and to create national blood safety standards. In addition, the program plans to scale up HIV/AIDS awareness among officials at all levels, the general population and high-risk groups. Civil society organizations are expected to play an important role in increasing awareness and advocacy under the program, SABA News reports.

Yemen was one of the first countries in the Middle East and North Africa to include HIV/AIDS in its national development agenda, SABA News reports. The government approved a national HIV/AIDS strategy in 2001 and created a national HIV/AIDS task force in 2003 (SABA News, 5/12).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV